Goldman Sachs’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-380,100
Closed -$21.4M 7288
2016
Q1
$21.4M Buy
380,100
+319,900
+531% +$18.9M 0.01% 1674
2015
Q4
$4.06M Sell
60,200
-129,800
-68% -$6.95M ﹤0.01% 3030
2015
Q3
$8.81M Buy
190,000
+150,000
+375% +$7.27M ﹤0.01% 2348
2015
Q2
$2.15M Buy
+40,000
New +$2.04M ﹤0.01% 3770

Other funds holding NVRO

Goldman Sachs's NVRO Position: Q2 2025 in Review

Goldman Sachs sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 2,072,813 shares — an estimated $12.1M sold.

Goldman Sachs first reported a position in NVRO in Q4 2014 and held it in 41 quarters. The position peaked at $139M in Q1 2017. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Goldman Sachs reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Goldman Sachs sold 2,072,813 NEVRO CORP. shares in Q2 2025, an estimated $12.1M.
  • Goldman Sachs first reported a position in NEVRO CORP. in Q4 2014 and held it in 41 quarters.
  • Goldman Sachs's NEVRO CORP. position peaked at $139M in Q1 2017.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Goldman Sachs's 13F filing for Q2 2025, filed 14 Aug 2025.